To understand if these alterations reflected a defect inherent to T-cells, we went on to investigate T-cell activation in vitro using isolated, highly pure native polyclonal CD4+/CD8+ lymphocyte preparations isolated 10 d post SIRS/sepsis. The gene discussed is CD8A; the disease is systemic inflammatory response syndrome.